Select Page

3D printing poised to disrupt healthcare

3D printing poised to disrupt healthcare

Written by David

November 28, 2018

Osseus Fusion Systems’ 3D printed titanium spinal implants won clearance from the Food and Drug Administration earlier this year, joining more than 100 devices and one drug currently on the market manufactured on 3D printers. FDA Commissioner Scott Gottlieb has called 3D printing a transformative technology that could disrupt medical practice, and the agency is scrambling to keep abreast of new regulatory challenges. ​ Known as additive manufacturing, the process involves production of three-dimensional objects using a digital file. The printer layers successive images or files on top of one another until a solid 3D object is formed. The process allows designers to create 3D models of a patient’s anatomy for use in diagnosis or surgical planning. An emerging biotechnology company was at a point where timelines to get label text approved and in place was pushing almost 6 months for every study. Learn more about how the team […]

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

You May Also Like…

Pin It on Pinterest

Share This

Share this post with your friends!

Shares